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Natural killer (NK) cells are key mediators in the control of
cytomegalovirus infection. Here, we show that Epstein–Barr virus-
induced 3 (EBI3) is expressed by human NK cells after NKG2D or IL-12
plus IL-18 stimulation and by mouse NK cells during mouse cytomeg-
alovirus (MCMV) infection. The induction of EBI3 protein expression in
mouse NK cells is a late activation event. Thus, early activation events
of NK cells, such as IFNγ production and CD69 expression, were not
affected in EBI3-deficient (Ebi3−/−) C57BL/6 (B6) mice during MCMV
infection. Furthermore, comparable levels of early viral replication in
spleen and liver were observed in MCMV-infected Ebi3−/− and wild-
type (WT) B6 mice. Interestingly, the viral load in salivary glands and
oral lavage was strongly decreased in the MCMV-infected Ebi3−/− B6
mice, suggesting that EBI3 plays a role in the establishment of MCMV
latency. We detected a decrease in the sustained IL-10 production by
NK cells and lower serum levels of IL-10 in theMCMV-infected Ebi3−/−
B6 mice. Furthermore, we observed an increase in dendritic cell mat-
uration markers and an increase in activated CD8+ T cells. Thus, EBI3
dampens the immune response against MCMV infection, resulting in
prolonged viral persistence.
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Natural killer (NK) cells play an essential role in host defenseagainst viral infections, particularly herpesviruses, such as
cytomegalovirus (CMV) (1). During infection, NK cell activation is
tightly controlled by the integration of signals derived from acti-
vating and inhibitory receptors, through the interaction with target
or accessory cells, and from cytokine receptors. Several activating
NK receptors exist, including the activating killer cell Ig-like re-
ceptors (KIRs) in humans, the activating Ly49 receptors in rodents,
NKG2D, the natural cytotoxicity receptors (i.e., NKp30, NKp44,
and NKp46), and the activating Fc receptor CD16 (2). The acti-
vating receptors recognize either stress-induced ligands on viral-
infected cells, virus-encoded proteins, or Ig-coated cells. Signals from
the activating receptors promote cytoskeletal rearrangements and
proliferation, as well as secretion of cytolytic granules and cytokines
(2). The inhibitory receptors Ly49 and KIR recognize polymorphic
major histocompatibility complex class I ligands that can dampen or
prevent the NK cells from attacking self (2).
NK cell-mediated control of viral infections has been studied
extensively in mice infected with mouse CMV (MCMV). NK cells
contribute directly to the early control of MCMV infection by elim-
inating the virus-infected cells. In C57BL/6 (B6) mice, Ly49H+ NK
cells recognize MCMV-infected cells expressing the virus-encoded
protein m157. This antigen-specific recognition leads to NK cell
activation (3), as well as expansion and differentiation of memory
NK cells (4), which is dependent on the DAP12 adapter protein,
the costimulatory receptor DNAM-1, and the proinflammatory
cytokine IL-12 (4–6). The DAP10 adapter protein and the cytokines
IL-33 and IL-18 are required for optimal expansion of Ly49H+ NK
cells, but not for memory NK cell differentiation (7–9). In ad-
dition, optimal activation of both Ly49H+ and Ly49H− NK cells
and production of IFNγ during MCMV infection is critically
dependent on both IL-12 and IL-18 (9, 10). In addition to
mediating early control of MCMV infection, NK cells also play
a role in shaping the subsequent adaptive immune responses.
Crosstalk between NK cells and dendritic cells (DCs) early
during MCMV infection affects the outcome of the T-cell re-
sponses. IL-10 secreted by various immune cells, including NK
cells, dampens the T-cell response by negatively affecting the
maturation of DCs, and in the absence of IL-10 secretion of
IFNγ and TNFα by NK cells enhances the maturation of DCs,
which boosts the T-cell response (11).
The cytokine Epstein–Barr virus-induced 3 (EBI3) was first
identified in B cells infected with Epstein–Barr virus (12), but
several other cells from the immune system have also been found
to express and secrete EBI3, including activated DCs, regulatory
T cells, and regulatory B cells (13–15). EBI3 belongs to the IL-12
family of cytokines that consists of the four heterodimeric cyto-
kines IL-12 (p35/p40), IL-23 (p19/p40), IL-27 (p28/EBI3), and
IL-35 (p35/EBI3), which signal through unique pairings of the five
receptor chains IL-12Rβ1, IL-12Rβ2, IL-23R, gp130, and WSX-1
(16). IL-27 and IL-35 lack disulfide linkage and pair poorly and are
therefore less stable and secreted in much lower amounts than the
disulfide-linked family members IL-12 and IL-23 (16). It has been
well-documented that IL-12 and IL-23 function as proin-
flammatory cytokines. However, studies with IL-27 and IL-35
have been complicated by their instability in solution and the lack
of specific reagents. IL-27 has been proposed to possess both
proinflammatory and anti-inflammatory properties in that it can
promote Th1 polarization (17) but also stimulate the production of
IL-10 (18, 19). IL-35 appears to possess anti-inflammatory prop-
erties with the predominant mechanism being suppression of T-cell
proliferation and conversion of naive T cells into IL-10–producing
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T cells (13). It has been speculated that EBI3 can be secreted and
function as a homodimer; however, this remains to be elucidated
(15, 16). Here we identify activated human and mouse NK cells as
producers of EBI3 and show that EBI3 promotes the persistence
of MCMV infection.
Results
Gene Expression Analysis of NKL Cells Stimulated Through Activating
Receptors. We investigated the global gene expression profile of
human NK cells stimulated through various activating receptors to
identify genes involved in the regulation of NK cell functions. We
used the human-transformed NK cell line, NKL, stably transduced
with either the activating mouse Ly49H receptor or the activating
human KIR2DS1 receptor (Fig. S1A). NKL cells, which constitu-
tively express the activating NKG2D receptor (Fig. S1A), were
stimulated with saturating amounts of plate-bound isotype-matched
control Ig or receptor-specific monoclonal antibodies (mAbs), and
the RNA was extracted and used for deep sequencing. Before anal-
ysis the quality of the gene expression data was verified using principal
component analysis (PCA) and by calculating the Pearson correlation
coefficient for the experimental replicates (Fig. S1 B and C).
In our gene expression analysis of the activated NKL cells, we
scrutinized genes that were up- and down-regulated with at least
a 1.5-fold change relative to the control samples. A total of 254,
158, or 596 genes were identified to be up- and down-regulated
4 h after KIR2DS1, NKG2D, or Ly49H stimulation, respectively
(Fig. 1A and Dataset S1). We examined the 133 genes that were
commonly regulated by all three stimulations (Fig. 1A) by gene
set enrichment analysis (GSEA). GSEA is a pathway-based
analysis that detects changes in expression of genes in entire
pathways or gene sets and is therefore more robust than analyses
based upon individual genes. GSEA identified 20 gene sets and
pathways that were significantly different relative to the control
samples (Fig. 1B). The gene set with the highest enrichment
score identified by GSEA was “cytokines,” which included many
genes known to be expressed by activated NK cells, i.e., IFNG,
FASLG, XCL1, CCL1, CCL3, CCL4, and CCL5 (2, 20, 21) (Fig.
1C). Interestingly, we detected an up-regulation of EBI3 in the
activated NKL cells (Fig. 1C). EBI3 expression has recently been
shown to be up-regulated in human NK cells in response to Fc re-
ceptor activation, but only in the presence of IL-12 (22), confirming
our results that activated NK cells can express EBI3; however, to our
knowledge no previous studies have examined EBI3 protein ex-
pression and secretion by human and mouse NK cells. Furthermore,
the effect of EBI3 on NK cell function in vivo is unknown.
EBI3 Protein Expression and Secretion Is Increased in Human NK Cells
in Response to Receptor- and Cytokine-Mediated Stimulation. NKL
cells constitutively express EBI3, which was significantly increased
upon receptor-mediated stimulation (Fig. 2A). IL12A (i.e., p35)
was also constitutively expressed in NKL cells, but its expression
was not increased after receptor-mediated stimulation (Fig. 2A).
In agreement with the gene expression data, the majority of or all
NKL cells express EBI3 and p35, respectively (Fig. 2B), and the
amount of intracellular EBI3, but not p35, proteins was increased
following receptor-mediated stimulation for 24 h (Fig. 2 C and F,
respectively). In addition, the intracellular EBI3 protein level was
increased in response to IL-12 plus IL-18 treatment for 24 h (Fig.
2D). EBI3 and p35 protein was found in the supernatant of NKL
cells after culture, but only EBI3 secretion was increased after
stimulation (Fig. 2 E and G), which was consistent with the in-
tracellular protein levels observed. To confirm that EBI3 is also
expressed by primary human NK cells, we examined the in-
tracellular EBI3 protein level in resting and activated CD56dim
(i.e., mature) and CD56bright (i.e., immature) NK cells derived from
healthy human blood donors. Resting NK cells did not express
EBI3 (Fig. S2 A and B), suggesting that the constitutive expression
of EBI3 observed in NKL cells is due to cell transformation and/or
the in vitro culture conditions. Treatment with IL-12 alone for 24 h
did not induce EBI3 protein expression, and only a slight increase
was observed after treatment with IL-18 alone (Fig. S2A). How-
ever, treatment with IL-12 in combination with IL-18 for 24 h led
to a robust induction of EBI3 protein expression in both CD56bright
and CD56dim NK cells (Fig. S2 A and B). Priming with IL-2 for 24 h
did not induce EBI3 protein expression; however, a significant
increase was observed after stimulation of IL-2–primed NK cells
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Fig. 1. Gene expression analysis of NKL cells stimulated through activating receptors. (A) RNA was isolated from NKL cells stimulated with the indicated plate-
bound Abs for 4 h and then analyzed by deep sequencing. Shown is the number of genes that were up- and down-regulated with at least a 1.5-fold change in the
receptor-stimulated NKL cells relative to the control-treated cells (n = 2–4 independent experiments). (B and C) GSEA was performed on the deep-sequencing
data. (B) Shown are the strongest associated gene sets/pathways when analyzing genes that were significantly differentially expressed between NKG2D-stim-
ulated NKL cells versus control-treated cells at 4 h. The scale is given as DAVID-reported –log10 (false discovery rate) value, i.e., the gene-set score. The score of all
gene sets is shown, but only the top 20 are labeled. (C) Shown is a volcano plot of the genes contained in the “cytokine” gene set, which had the strongest
enrichment score in B. The x axis indicates a log2 fold-change, with positive values corresponding to genes for which expression is up-regulated.
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with plate-bound anti-NKG2D mAb for 24 h (Fig. S2C). In con-
trast to EBI3 expression, the majority of resting NK cells consti-
tutively expressed p35 (Fig. S2A). We did not detect any protein
expression of p28 (Fig. 2B). NKL cells stained positive for both
gp130 and IL-12Rβ2 as detected by intracellular protein staining
(Fig. 2H, “intracellular”). Furthermore, gp130 was detected at the
cell surface of NKL cells, but only after incubating the cells with
the anti-gp130 Ab at 37 °C (Fig. 2H, “surface”), suggesting that the
gp130 receptor is rapidly recirculated at the cell surface of the
NKL cells. Resting primary human NK cells expressed low levels
of gp130 at the cell surface, but the expression was increased in
response to IL-12 plus IL-18 treatment, with the strongest in-
duction observed in the CD56bright NK cells (Fig. S2D). Further-
more, the majority of CD56bright NK cells and all of the CD56dim
NK cells constitutively expressed IL-12Rβ2 as detected by in-
tracellular protein staining (Fig. S2E). No cell-surface staining of
IL-12Rβ2 was detected by flow cytometry (Fig. 2H, “surface”).
MCMV Infection Induces EBI3 Expression in Mouse NK Cells. Based on
our results with human NK cells and the NKL cells transduced to
express Ly49H, we examined if MCMV infection could be used
as an in vivo model system to study the functional role of EBI3.
During MCMV infection we detected an increase in the in-
tracellular EBI3 protein level in splenic NK cells (Fig. 3 A and B),
whereas no difference was detected in T cells, B cells, and DCs
from the same samples (Fig. S3A). The increase in EBI3 protein
expression in mouse NK cells was strongest at day 2.5 postinfection
(p.i.) (Fig. 3B) with the highest levels observed in MCMV-specific
Ly49H+ (Fig. 3 A and B). The cell-surface expression of gp130 was
increased on splenic NK cells in response to MCMV infection
(Fig. 3 C and D), which indicates a possibility for an autocrine
effect. This increase in gp130 surface expression was specific for
NK cells, as the surface expression on T cells, B cells, and DCs was
either decreased or unchanged (Fig. S3B). p35, but not p28, pro-
tein expression was increased in splenic NK cells in response to
MCMV infection (Fig. 3 E and F), and like EBI3, the strongest
induction of p35 protein expression was observed at day 2.5 p.i.
(Fig. 3E).
EBI3-Deficient Mice Show Decreased MCMV Replication in the Salivary
Glands and Oral Lavage. To examine the functional role of EBI3
in vivo, we infected wild-type (WT) and EBI3-deficient (Ebi3−/−)
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Fig. 2. EBI3 protein expression is increased in response to receptor- and cytokine-mediated stimulation. (A) Gene expression data for EBI3 and p35 in NKL
cells stimulated with the indicated plate-bound Abs for 4 h (circle) or 18 h (square) were obtained from the deep-sequencing analysis (n = 2–4 independent
experiments; statistical analysis is shown for 4-h samples). (B) Intracellular EBI3, p28, and p35 protein expression was examined by flow cytometry in resting
NKL cells. Data are representative of three independent experiments. (C and D) Intracellular EBI3 protein expression was measured by flow cytometry in NKL
cells stimulated with (C) plate-bound Abs or (D) IL-12+IL-18 for 24 h. (C) Data show mean ± SD from three independent experiments. (D) Data are repre-
sentative of three independent experiments. (E) NKL cells were stimulated with plate-bound Abs, media, or IL-12+IL-18 for 24 h, and EBI3 was detected in the
supernatant by Western blot analysis. The graphs show mean ± SD from two or three independent experiments. (F) Intracellular p35 protein expression was
measured by flow cytometry in NKL cells stimulated with plate-bound Abs for 24 h. (G) NKL cells were stimulated with media or plate-bound Abs for 24 h, and
p35 was detected in the supernatant by Western blot analysis. The graphs show mean ± SD from three independent experiments. (H) Surface and intracellular
protein expression of gp130 and IL-12Rβ2 was examined by flow cytometry in resting NKL cells. Data are representative of three independent experiments.
Statistical analysis was performed by two-tailed unpaired Student’s t test (*P < 0.05, **P < 0.01, and ***P < 0.001).
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C57BL/6 (B6) mice with MCMV. The Ebi3−/− B6 mice lack exons
2–5 of the Ebi3 gene, corresponding to amino acids 24–228 of the
EBI3 protein (23), which includes the functional fibronectin type 3
domain found at amino acids 128–216 (24). Thus, the truncated
version of EBI3 likely to be present in the deficient mice would be
nonfunctional. No difference was observed between the two mouse
strains with regard to the percentages of splenic NK cells and the
immature and mature NK cell subsets (Fig. S4 A and B). Fur-
thermore, the splenic NK cells showed similar expression levels of
several NK receptors, including KLRG1, Ly49H, Ly49C/I, Ly49D,
Ly49A, NKG2,A,C,E, NKp46, and NKG2D (Fig. 4A and Fig.
S4C). Thus, EBI3 deficiency is not associated with any phenotypic
or maturational defects in the NK cells. During MCMV infection,
the early activation of splenic NK cells, measured by CD69 ex-
pression and IFNγ production at day 1.5 p.i., was comparable
between the WT and Ebi3−/− B6 mice (Fig. 4 B and C, respec-
tively). Furthermore, no difference in the viral load in liver and
spleen from the mice was observed at day 4 p.i. (Fig. 4 D and E).
We also observed a similar expansion of peripheral blood
KLRG1hi Ly49H+ NK cells in the MCMV-infected mice (Fig. 4A).
However, the viral load was significantly (P < 0.05) decreased in
the blood in the MCMV-infected Ebi3−/− B6 mice at day 7 and day
14 p.i. (Fig. 4F). Interestingly, we found that MCMV was cleared
most efficiently in the salivary glands and oral lavage of the Ebi3−/−
B6 mice (Fig. 4 G and H), which are important sites for virus
persistence and dissemination (25).
EBI3 Promotes IL-10 Production by NK Cells and Negatively Affects the
Maturation of DCs and Activation of CD8+ T Cells During MCMV
Infection. Several cells in the immune system, including NK cells,
produce IL-10 early after MCMV infection. The early production
of IL-10 promotes virus replication in the salivary glands by neg-
atively affecting the maturation of DCs, leading to poor priming of
T cells (26, 27). We found that splenic Ly49H+ and Ly49H– NK
cells from the mice produced similar levels of IL-10 at day 2.5
post-MCMV infection (Fig. 5A). However, the IL-10 production
was significantly decreased at day 3.5 p.i. in the Ebi3−/− B6 mice
(Fig. 5A), suggesting that EBI3 plays an essential role in the sus-
tained, but not initial, production of IL-10 by NK cells during
MCMV infection. The serum level of IL-10 peaks at day 5 p.i.
during MCMV infection (26). We found that the levels of IL-10 in
sera were significantly decreased in the MCMV-infected Ebi3−/−
B6 mice (Fig. 5B), indicating that the overall production of IL-10
was affected in the mice. We further examined the impact of EBI3
deficiency on DC maturation and T-cell activation, both of which
are affected by IL-10 during MCMV infection (26, 27). We ob-
served higher levels of the maturation markers CD86 and CD40
on splenic DCs derived from the Ebi3−/− B6 mice at day 5 p.i. (Fig.
5C). Furthermore, the percentage of activated peripheral CD8+ T
cells (i.e., NKG2D-positive CD8+ T cells) was increased in the
MCMV-infected Ebi3−/− B6 mice (Fig. 5D). Thus, together these
results indicate that EBI3 promotes persistent MCMV infection,
presumably in part by sustaining IL-10 production, which nega-
tively affects the maturation of DCs and the activation of T cells.
Discussion
In this study, we show that both human and mouse NK cells ex-
press EBI3 protein after stimulation. Furthermore, we describe a
previously unidentified pathway wherein EBI3 affects the estab-
lishment of MCMV latency. Interestingly, mice deficient in EBI3
showed almost no viral replication in salivary glands and oral la-
vage, which are the main sites for viral persistence and dissemi-
nation (25), whereas the early viral replication in the spleen and
liver was comparable between the EBI3-deficient and WT mice.
MCMV-infected mice displayed lower levels of IL-10 in the ab-
sence of EBI3, an effect that was observed in splenic NK cells at
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day 3.5 p.i. and in the serum at day 5 p.i. As reported previously,
production of IL-10 early during MCMV infection is important for
limiting DC maturation and T-cell activation to prevent harmful
immune-mediated tissue damage in the host (26, 27). During
MCMV infection, IL-10 production by NK cells and other immune
cells can suppress the maturation DCs, leading to poor priming of
CD4+ T cells (26). Furthermore, NK cell-mediated IL-10 pro-
duction during MCMV infection regulates CD8+ T-cell activation,
where a blockade of IL-10 increases the CD8+ T-cell response
against MCMV (27). We detected an increase in both the matu-
ration markers of DCs and the percentage of activated CD8+
T cells in the MCMV-infected EBI3-deficient mice, indicating that
the observed decrease in IL-10 production in the EBI3-deficient
mice was able to enhance the subsequent T-cell response. In this
study we found that EBI3 affects the production of IL-10 by NK
cells during MCMV infection, as measured by direct ex vivo in-
tracellular staining for IL-10 protein. However, it remains to be
determined whether the production of IL-10 by other cell subsets,
such as myeloid cells and CD4+ T cells, is affected by EBI3 during
MCMV infection. Although beyond the scope of this article, it is
also possible that EBI3 plays an additional role(s) in MCMV
latency that is independent of IL-10. Production of IL-10 early
during MCMV infection depends on the magnitude of viral rep-
lication (28). Following a low-dose MCMV infection, viral repli-
cation is controlled rapidly within a couple of days and only low
levels of IL-10 are produced to limit the immune response. In
contrast, during a high-dose MCMV infection, which leads to
sustained and elevated levels of viral replication, sustained and
higher amounts of IL-10 are needed to limit the immune response
and prevent tissue damage (28). Our data suggest that EBI3 is
essential to sustain IL-10 production during a high-dose MCMV
infection.
EBI3 can interact with p28 to form IL-27 heterodimers or with
p35 to form IL-35 heterodimers (16). We detected p35, but never
p28, protein expression in human and mouse NK cells. Both EBI3
and p35 were constitutively secreted by the NKL cells. Therefore,
in our experimental settings activated NK cells do not produce or
secrete IL-27 heterodimers. For several reasons we were not able
to distinguish between IL-35 heterodimers and EBI3 homodimers
and therefore were unable to determine which of the two species
are predominantly formed and secreted by the activated NK cells.
First, there are no blocking Abs that can distinguish between EBI3
and IL-35. Second, IL-35 is very unstable in solution (16), which
makes the detection of small amounts by ELISA or immunopre-
cipitation difficult or impossible. Finally, mice deficient in p35 also
lack IL-12, a cytokine essential for NK cell activation and pro-
liferation in response to MCMV infection (6, 10). EBI3 protein
and the gp130 receptor was up-regulated in splenic NK cells
during MCMV infection, whereas no up-regulation was observed
in T cells, DCs, or B cells at the time points examined in this study.
However, the basal or background level differed between the
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various cell types examined. We cannot distinguish between the
role of EBI3 derived from NK cells versus other cell types during
MCMV infection as there presently is no conditional knockout of
Ebi3 to definitively address this issue.
The immune system has established multiple layers of control
to ensure effective protection against viral infections, but at the
same time to keep the immune system in check to avoid excessive
inflammation and autoimmunity. NK cells play a key role in the
early control of CMV replication and in modulating the adaptive
immune response against the virus (1). Despite the cooperative
work between NK cells and T and B cells, CMV can establish
persistent infections in mice and humans by exploiting host im-
mune inhibitory pathways to modulate the virus–host balance
toward its own benefit (25). Induction of the regulatory cytokine
IL-10 during infection represents one such immune inhibitory
pathway (29). Our results suggest that the induction of EBI3
represents an inhibitory pathway that can be exploited by CMV
to establish latent infection. Whether EBI3 can affect the per-
sistent infection of other herpesviruses remains to be elucidated.
However, it is noteworthy that Epstein–Barr virus, another virus
that can establish latency by exploiting the IL-10 inhibitory
pathway (25), is also a strong inducer of EBI3 expression (12).
Materials and Methods
WT and EBI3-deficient (B6.129 × 1Ebi3tm1Rsb/J) mice on a C57BL/6 background
were maintained and used in accordance with guidelines of the University of
California at San Francisco (UCSF) Institutional Animal Care and Use
Committee. Peripheral blood mononuclear cells (PBMCs) were isolated from
blood obtained from the Stanford Blood Center or the Blood Centers of the
Pacific under an Institutional Review Board approved protocol (IRB# 10–
00265) by density gradient centrifugation using Ficoll-Paque PLUS (GE
Healthcare Bio-Sciences AB).
Reagents, vendors, and protocols are included in SI Materials and Meth-
ods. Details of the mice and cells used, as well as details of the methods used
including MCMV infection, in vitro stimulation of NK cells, real-time PCR,
flow cytometry, Western blot analysis, IL-10 ELISA, and deep sequencing are
presented in SI Materials and Methods. Additional questions pertaining to
methods, protocols, and reagents are available upon request.
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